<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23472128</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>12</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2013</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e58001</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0058001</ELocationID>
            <Abstract>
                <AbstractText>Apurinic/apyrimidinic endonuclease 1 (APE1), which has the dual functions of both DNA repair and redox activity, has been reported to be highly expressed in non-small cell lung cancer (NSCLC), and this appears to be a characteristic related to chemotherapy resistance. In this study, we identified serum APE1 autoantibodies (APE1-AAbs) in NSCLC patients and healthy controls by immunoblotting and investigated the expression of APE1-AAbs by indirect ELISA from the serum of 292 NSCLC patients and 300 healthy controls. In addition, serum APE1-AAbs level alterations of 91 patients were monitored before and after chemotherapy. Our results showed that serum APE1-AAbs can be detected in both NSCLC patients and healthy controls. Serum APE1-AAbs were significantly higher than those of healthy controls and closely related to APE1 antigen levels both in tumor tissues and the peripheral blood. Moreover, the change in levels of serum APE1-AAbs in NSCLC is closely associated with the response to chemotherapy. These results suggest that APE1-AAbs is a potential tumor marker and predictor of therapeutic efficacy in NSCLC.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dai</LastName>
                    <ForeName>Nan</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cao</LastName>
                    <ForeName>Xiao-Jing</ForeName>
                    <Initials>XJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Meng-Xia</ForeName>
                    <Initials>MX</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qing</LastName>
                    <ForeName>Yi</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liao</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lu</LastName>
                    <ForeName>Xian-Feng</ForeName>
                    <Initials>XF</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Shi-Heng</ForeName>
                    <Initials>SH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Zheng</ForeName>
                    <Initials>Z</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Yu-Xin</ForeName>
                    <Initials>YX</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Dong</ForeName>
                    <Initials>D</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>03</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000941">Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 4.2.99.18</RegistryNumber>
                <NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 4.2.99.18</RegistryNumber>
                <NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000941" MajorTopicYN="N">Antigens</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>11</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2013</Year>
                <Month>01</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>3</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>3</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23472128</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0058001</ArticleId>
            <ArticleId IdType="pii">PONE-D-12-35184</ArticleId>
            <ArticleId IdType="pmc">PMC3589448</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Antioxid Redox Signal. 2009 Mar;11(3):621-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18715144</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2004 Jul-Aug;24(4):2127-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15330152</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2011 Feb;22(2):383-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20675559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antioxid Redox Signal. 2009 Mar;11(3):601-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18976116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Treat Rev. 2010 Aug;36(5):425-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20056333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Immunol Immunother. 1998 Aug;46(6):345-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9756419</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Proteomics. 2011 Jun;10(6):M110.005330</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21474795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2001 Nov-Dec;21(6A):4041-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11911289</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 2009 Sep 18;282(2):159-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19380192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mutat Res. 2000 Oct 16;461(2):83-108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11018583</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Leuk Res. 2011 Jul;35(7):965-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21570119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Carcinogenesis. 2007 Oct;28(10):2082-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17522062</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17560642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung Cancer. 2003 Feb;39(2):165-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12581569</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2005 Apr 14;434(7035):907-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15829965</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Immunol. 2010 Jul;71(7):643-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20433885</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20610543</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mass Spectrom Rev. 2007 May-Jun;26(3):451-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17407130</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Mol Med. 2011 Oct;15(10):2013-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21651719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2008 Dec;28(23):7066-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18809583</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1993 Feb 25;328(8):546-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8381208</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung Cancer. 2009 Dec;66(3):298-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19324449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15706084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2008 Sep;19 Suppl 7:vii25-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18790961</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2010 Jul 29;29(30):4330-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20498636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CJEM. 2006 Jan;8(1):19-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17175625</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Ther. 2004 Jun;3(6):679-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15210853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung Cancer. 2008 Dec;62(3):364-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18485524</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Cycle. 2006 Feb;5(3):250-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16418580</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Causes Control. 2010 Jun;21(6):959-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20217210</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2004 May 20;350(21):2129-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15118073</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2010;5(12):e15003</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21170350</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(7):e40759</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22815807</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 2005 Dec 18;230(2):187-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16297705</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Oncol. 2009 Nov;35(5):1069-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19787261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 1995 Dec;1(12):1463-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9815945</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung Cancer. 2008 May;60(2):277-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18061304</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2011 Mar 15;17(6):1474-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21138858</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2000 Sep;1(3):181-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10973269</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Res. 2008 Jan;18(1):27-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18166975</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>DNA Repair (Amst). 2012 Apr 1;11(4):374-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22284908</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2008;3(10):e3409</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18923710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2008 Nov 1;26(31):5060-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18794547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS J. 2009 Dec;276(23):6880-904</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19860826</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2010 Oct;21 Suppl 7:vii199-202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20943615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21296855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 1998 Oct 21;90(20):1563-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9790550</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta. 2006 Apr;1765(2):223-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16480833</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Proteomics. 2011;2011:726869</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22229091</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Biomark. 2010;6(3-4):123-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20660959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta. 2006 Apr;1762(4):398-403</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16483750</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gene. 2005 Jul 18;354:140-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15979824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 2006 Feb 20;233(1):48-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15913883</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 2006 May 8;236(1):64-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15992994</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Autoimmunity. 2008 Mar;41(2):123-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18324481</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>